Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NapBiome: Targeting Gut Microbiota and Sleep Rhythm to Improve Developmental and Behavioral Outcomes in Early Childhood

NCT06396689 is registered in ClinicalTrials.gov with Petra Zimmermann as lead sponsor.

NCT NCT06396689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06396689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NapBiome: Targeting Gut Microbiota and Sleep Rhythm to Improve Developmental and Behavioral Outcomes in Early Childhood
Lead sponsor
Petra Zimmermann
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
February 28, 2029
Enrollment
380 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neurobehavioral manifestations, sleep problem